Skip to main content
Balkan Medical Journal logoLink to Balkan Medical Journal
. 2016 May 1;33(3):301–307. doi: 10.5152/balkanmedj.2016.140555

Diffusion Weighted MR Imaging of Breast and Correlation of Prognostic Factors in Breast Cancer

İnci Kızıldağ Yırgın 1,, Gözde Arslan 2, Enis Öztürk 3, Hakan Yırgın 4, Nihat Taşdemir 5, Ayşegül Akdoğan Gemici 6, Fatma Çelik Kabul 3, Eyüp Kaya 3
PMCID: PMC4898989  PMID: 27308074

Abstract

Background:

Through Diffusion Weighted Imaging (DWI), information related to early molecular changes, changes in the permeability of cell membranes, and early morphologic and physiologic changes such as cell swelling can be obtained.

Aims:

We investigated the correlation between the prognostic factors of breast cancer and apparent diffusion coefficient (ADC) in DWI sequences of malignant lesions.

Study Design:

Retrospective cross-sectional study.

Methods:

Patients who were referred to our clinic between September 2012 and September 2013, who underwent dynamic breast MRI before or after biopsy and whose biopsy results were determined as malignant, were included in our study. Before the dynamic analysis, DWI sequences were taken. ADC relationship with all prognostic factors was investigated. Pearson correlation test was used to compare the numerical data, while Spearman correlation and Fisher exact tests were used to compare the categorical data. The advanced relationships were evaluated with linear regression analysis and univariate analysis. The efficiency of the parameters was evaluated using ROC analysis. The significance level (P) was accepted as 0.05.

Results:

In total, 41 female patients with an average age of 49.4 years (age interval 21–77) and 44 lesions were included into the study. In the Pearson correlation test, no statistically significant difference was determined between ADC and the patient’s age and tumor size. In the Spearman correlation test, a statistically significant difference was determined between nuclear grade (NG) and ADC (r=−0.424, p=0.04); no statistically significant correlation was observed between the other prognostic factors with each other and ADC values. In the linear regression analysis, the relationship of NG with ADC was found to be more significant alone than when comparing all parameters (corrected r2=0.196, p=0.005). Further evaluations between the NG and ADC correlation were carried out with ROC analysis. A statistically significant difference was determined when NG 1 separately was compared with NG 2 and 3 (p=0.03). A statistically significant difference was also determined (p=0.05) in the comparison of NG 1 with only NG 3. No statistically significant difference was determined when NG 2 separately was compared with NG 1 and NG 3 and when NG 3 separately was compared with NG 1 and 2 (p=0.431, p=0.097),

Conclusion:

We found that ADC values obtained by breast DWI showed a higher correlation with the NG of breast cancer, which is an important factor in the patient’s treatment. Predictions can be made about NG by analyzing the ADC values. Additional studies are needed, however, and the ADC value of the lesion can be used as a prognostic factor proving the aggressiveness.

Keywords: Breast cancer, breast MR, diffusion


Breast cancer is the most common form of cancer among women worldwide and is also responsible for the most cancer-related deaths in female cancer patients (1). The number of tumor-related features available to predict the prognosis of patients with breast cancer has grown considerably in recent years. Prognostic factors of breast cancer include histological features (histological subtype, histological grade, nuclear grade (NG), lymphovascular invasion), lymph node status, steroid hormone receptors status, age (<35 years) and size of tumor (>2 cm) (1,2).

Quantitative histopathology can improve the accuracy of prognosis when combined with other objective prognostic criteria, and can also potentially predict response to therapy. Histopathological grade is currently based on the degree of tubule formation, number of mitoses, and NG in routine sections. NG is one of the most important prognostic and predictive markers, and has provided valuable information in many cases (1,2).

Mammography (MG), ultrasound (US) and magnetic resonance imaging (MRI) can help to identify breast lesions more accurately but, nevertheless, remain insufficient for fully characterizing identified lesions. Diffusion-weighted imaging (DWI) is based on the movement of water molecules during the interval of excitation. This motion is affected by the biophysical characteristics of tissue, such as the cell density, membrane integrity and microstructure. Lesions can be characterized according to the diffusion of water in tissue, referred to as the apparent diffusion coefficient (ADC). DWI is sensitive to high cellularity due to proliferation in malignant tumor and the ADC value drops because of the restricted extracellular diffusion. DWI is being used more frequently in patient management due to its ability to evaluate the mobility of water within tissue, and to supply morphological information. Therefore, DWI is a useful tool for tumor detection and characterization as well as for monitoring and predicting treatment response. Although many studies have shown the usefulness of DWI and the ADC value for detecting primary breast lesions (35), few have reported correlations between the ADC value and prognostic factors.

To improve the specificity of breast MR analyses, new studies have been carried out by adding DWI to conventional and dynamic sequences. These studies have revealed that DWIs provide additional benefits with respect to dynamic breast MR analysis, by differentiating benign from malignant lesions and identifying breast cancer (610).

We investigated the correlation between the prognostic factors of breast cancer and ADC in DWI sequences of malignant lesions by retrospectively evaluating patients who applied to our department.

MATERIALS AND METHODS

Patients

Patients referred to our clinic between September 2012 and September 2013 who underwent dynamic breast MRI before or after biopsy, and whose biopsy results were determined as malignant, were included in this study. Ethics Committee approval was obtained from our hospital. Patients were informed of the study procedures and consent was taken before breast MRI. In total, 71 patients were analyzed, but 30 were excluded: 12 because they had received neo-adjuvant chemotherapy and endocrine treatment, 13 had in situ ductal carcinoma on histopathologic evaluation, 2 had medullary carcinoma, 2 had tubular carcinoma, and 1 was excluded for non-diagnostic-related, technical reasons. Consequently, 41 female patients and 44 lesions were included in the study. The patients’ mean age was 49.4 years (range: 21–77 years).

Imaging methods

Mammography analysis was performed in the craniocaudal and mediolateraloblique positions as part of a routine analysis protocol. The additional analysis protocols were administered in all patients, with US performed using a linear probe with 5–12 MHz resolution.

Breast MRI was performed with a 1.5 Tesla scanner (Avanto; Siemens, Erlangen, Germany) using standard bilateral breast coils. Spin-echo fat-suppressed T2-weighted axial, pre-contrast T1-weighted axial and sagittal, enhanced dynamic fat suppression axial, and post-contrast fat-suppression T1-weighted axial sequences were performed in all patients.

For dynamic sequences, enhanced images were obtained after the intravenous administration of contrast agents according to the weight (0.1–0.2 mmol/kg) of the patient. For dynamic-enhanced T1-weighted sequences, six images were taken of each section at 30-s intervals. Then, post-contrast fat suppression T1-weighted sequences were obtained. Post-contrast images were excluded from the corresponding pre-contrast images using the subtraction program of a specialized software package.

Before the dynamic analysis, DWI sequences were obtained with the following parameters: repetition time, 1,800 ms; echo time, 81 ms; number of slices, 15; disc-factor, 30; section thickness, 6 mm; Fov read, 380 mm; Fov phase, 100%; average, 16; concentration, 1; phase direction, anteroposterior; base resolution, 192; plane resolution, 80 μm; phase partial Fourier, 6/8; PAT mode, Grappa; b values, 0 and 750 sec/mm2; bandwidth, 1,446 Hz/pixel; echo spacing, 0.8 ms; epinephrine factor, 154; gradient mode, fast; and RF pulse, normal. ADC maps were created automatically by using b values of 0 and 750 sec/mm2. Calculations were made based on mean ADC maps of the circular sampling region of interest (ROI), with care taken to perform measurements in solid rather than necrotic/cystic areas. The ROIs were 10–100 mm2 in size (ROIs were drawn by a 10-year experienced radiologist).

Histopathologic analysis

The histopathological and NG grades of tumors were determined according to the Nottingham grading system (Elston-Ellis modification of the Scarff-Bloom-Richardson grading system). Estrogen receptors (ORs) and progesterone receptors (PgRs) were identified using mouse monoclonal antibody (Dako, Glostrup, Denmark); human epidermal growth factor receptor 2 (HER2) score was determined by the Hercep test (Dako), with scores > 3 considered HER2-positive.

Statistical analysis

The relationship between ADC and prognostic factors (sentinel lymph node status, tumor size, nuclear grade, lymphovascular invasion, HER2, ER, PgR status, patient age) was investigated. Pearson’s correlation was used to compare the numerical data, with Spearman’s correlation and Fisher’s exact tests used to compare the categorical data. Relationships were also evaluated by linear regression analysis and univariate analysis. The efficiency of the parameters was evaluated using relative operating characteristic (ROC) analysis. A P value < 0.05 was taken to indicate statistical significance. The statistical analyses were performed using the SPSS for Windows software package (ver. 19.0; SPSS Inc., Chicago, IL, USA).

RESULTS

In total, 16 (36.4%) and 25 (60.9%) patients were negative and positive, respectively, for sentinel lymph nodes. Lymphovascular invasion was negative in 18 (40.9%) and positive in 26 (59.1%) of the lesions. Eight (18.2%) lesions were NG 1, 23 (52.3%) were NG 2, and 13 (29.5%) were NG 3. A total of 32 (72.7%) lesions were HER2-negative, and 12 (27.3%) were HER2-positive, 9 (20.5%) lesions were ER-negative and 35 (79.5%) were ER-positive, and 13 (29.5%) lesions were PgR-negative, and 31 (70.5%) were PgR-positive. A single patient (2.4%) patient was <35 years of age, and 40 (97.6%) were >35 years of age. There were 11 (25%) lesions <2 cm in size, and 33 lesions >2 cm in size (Figure 1).

FIG. 1.

FIG. 1.

Nuclear grade classification

There was no significant association between the ADC and patient age or lesion size (Pearson’s correlation). There was a significant relationship between NG and the ADC (Spearman’s correlation, non-parametric data; R=−0.424, p=0.04). There were no significant correlations between the other prognostic factors, nor between the other prognostic factors and ADCs. However, there was a significant association between lesion size and lymphovascular invasion (R =−0.450, p=0.02).

On linear regression analysis, the relationship between NG and ADC was more significant compared to the relationships between all of the other parameters (corrected r2=0.196, p=0.005; Table 1 and 2). There were no significant correlations between any prognostic factors and ADCs in linear regression analyses for which NGs were not calculated.

TABLE 1.

The relationship between the apparent diffusion coefficient (ADC) and nuclear grade (NG) on linear regression analysis

R R square Adjusted R square Standard error
0.463 0.214 0.196 0.161

TABLE 2.

The relationship between ADC and all prognostic factors on linear regression analysis

Unstandardized coefficient B Standard error Standardized coefficient Beta t Significance
Age 0.003 0.002 −0.230 −1.504 0.142
Size 0.001 0.002 −0.085 −0.535 0.596
Axillary lymph node 0.0164 0.087 −0.442 −1.870 0.070
Lymphovascular invasion 0.193 0.093 0.535 2.072 0.046
Nuclear grade 0.120 0.040 −0.462 −2.999 0.005
HER2 0.017 0.060 0.042 0.284 0.778
OR 0.031 0.081 0.071 0.385 0.703
PgR −0.129 0.71 −0.332 −1.821 0.077

HER2: human epidermal growth factor receptor 2; OR: estrogen receptor; PgR: progesterone receptor

As a further step, a univariate analysis was performed in which the effect of NG alone on the ADC was found to be 25% (corrected r2=0.251, p=0.01). However, the effect of all of the prognostic factors on ADC was calculated as 30% (corrected r2=0.292).

Further evaluation of the relationship between NG and ADC was carried out with ROC analysis. There was a significant difference in the degree of association between ADC and NG 1 compared to between ADC and NGs 2 and 3 (p=0.03). A significant difference was also observed in the comparison between NG 1 and NG 3 only, but no significant difference was seen when NG 2 was compared in separate analyses with NGs 1 and 3, nor when NG 3 was separately compared with NGs 1 and 2 (p = 0.431 and p=0.097, respectively; Figures 2 and 3). Two of our patient’s images are provided (Figure 4 and 5).

FIG. 2.

FIG. 2.

Relative operating characteristic curve (ROC) in which NG 1 was compared with NGs 2 and 3 (area under the curve (AUC)=0.840)

FIG. 3.

FIG. 3.

ROC curve in which NG 1 was only compared with NG 3 (AUC=0.875)

FIG. 4. a–d.

FIG. 4. a–d.

A 41-year-old patient diagnosed with left breast invasive ductal carcinoma positive for axillary lymph node, lymphovascular invasion, NG 2, estrogen receptors (ORs), progesterone receptors (PgRs); and negative for human epidermal growth factor receptor 2 (HER2). Enhanced lesion was visualized on fat suppression, T1-weighted post-contrast analysis (a). Heterogeneously enhancing lesion in left breast visualized on subtraction images (b). Hyper-intense lesion on diffusion-weighted images (DWIs) (c). The apparent diffusion coefficient (ADC) value was measured as 1.07×10−3 mm2/sec on ADC maps (d).

FIG. 5. a–c.

FIG. 5. a–c.

A 35-year-old patient diagnosed with left breast invasive ductal carcinoma positive for axillary lymph node, lymphovascular invasion, and NG 3; and negative for ORs, PgRs, and HER2. Hyper-intense lesion on DWI (a), The ADC was measured as 0.95×10−3 mm2/sec on ADC maps (b), Enhanced lesion was visualized on fat suppression, T1-weighted post-contrast analysis (c).

In ROC curve analysis in which NG 1 was compared with NGs 2 and 3, the ADC cut-off value was calculated as 1.05×10−2 mm2/sec (Table 3). The relationships between all of the prognostic factors and ADC, according to the obtained cut-off value, were investigated with Pearson’s Chi-square and Fisher’s exact test. As with the other tests, no significant correlations were determined, except for between NG and ADC values (p=0.020).

TABLE 3.

ADC cut-off value according to the relative operating characteristic curve: comparison of NG 1 with NGs 2 and 3

Positive, if greater than or equal to: Sensitivity Specificity
−0.300 1.000 1.000
0.750 1.000 0.944
0.850 1.000 0.750
0.950 1.000 0.583
1.050 0.750 0.278
1.150 0.500 0.111
1.250 0.500 0.028
1.350 0.250 0.000
1.450 0.125 0.000
2.500 0.000 0.000

DISCUSSION

In recent years, several studies have indicated that DWI can be used to increase the specificity of breast MRI. DWI depends upon the diffusion of water molecules, and on random movement that occurs according to the principles of Brownian movement. Through DWI, information related to early molecular changes, changes in the permeability of cell membranes, and early morphological and physiological changes (such as cell swelling and/or cell lysis) can be obtained.

DWI has been used to evaluate cerebrovascular events and numerous types of intracranial lesion. Several studies have shown that DWI is efficient for evaluating the degree of disease and distinguishing benign from malignant breast lesions (8,1012). By using DWI, quantitative measurements can be obtained in ADC maps of the cellular intensity of the lesion and the diffusion gradient. For example, Kuroki et al. (10) showed that malignant breast lesions had lower ADCs than benign lesions, and invasive ductal carcinoma had lower ADCs compared to in situ ductal carcinoma.

In the present study, individual correlations between all prognostic factors and ADC values were investigated. In contrast to many previous studies, average ADC values were not calculated. A significant correlation was only determined between NG and ADC values; as the NG increased, ADC values decreased. No significant correlation was determined between any of the other prognostic factors and ADC values.

Kim et al. (13) found no correlations between any prognostic factor and ADC values and concluded that ADC values were beneficial for identifying malignant lesions, but were not related to the prognosis of the patient. The difference between these authors’ study and the present study was that we observed a significant correlation between NG and ADC values.

In a study by Kamitani et al. (14), in which the relationships between prognostic factors and ADC values were compared, higher ADC values were observed in cases that were positive for axillary lymph node, but ADC values were lower in cases that were positive for OR. No correlation was determined between any other factors and ADC values. High ADC values in cases that were positive for axillary lymph node were associated with micro-necrosis and fibrosis inside the lesion. In our study, we did not measure central necrotic/cystic components, and obtained measurements in particular from the solid peripheral region. Moreover, in a study by Razek et al. (15), lower ADC values were observed in cases positive for axillary lymph node, so no clear consensus has yet been reached regarding this association. These authors also investigated correlations between prognostic factors and ADC values and showed that histological grade, tumor size and axillary lymph node metastasis were significantly correlated with ADC; furthermore, as NG and tumor size increased, ADC values decreased. Additionally, ADC values were lower in cases that were positive for axillary lymph node.

Laura et al. (4) investigated the relationships between breast cancer biomarkers and ADC values and determined that ADC values were lower among OR-positive versus OR-negative cases; furthermore, HER2-negative cases had the highest ADC values. These authors also found a significant relationship between NG and ADC values, similar to the present study. In our study, a significant difference was observed between the degree of association between ADC values and NG 1 compared to between ADC values and NGs 2 and 3, but there was no difference when NG 3 was compared with NGs 1 and 2 in separate analyses. In the study of Laura et al., there was a significant difference between the degree of association between ADC values and NG 3 compared to between ADC values and NGs 1 and 2. This difference may be explained by the fact that the numbers of patients in each NG sub-group were different; nevertheless, both studies found an inverse correlation between NG and ADC values. In a study by Constantini et al. (16), the relationship between ADC values and tumor grade was investigated in 136 patients, with a significant difference determined between the strength of the association between ADC values and NG 1 relative to NGs 2 and 3.

Our study had some limitations. Because it used a retrospective design, a period of specific duration could not be determined between biopsy and MRI. MRI was performed in some patients before biopsy, and in others after biopsy. Furthermore, although the ADC measurement was performed in both solid and peripheral regions of the lesion, differences in ADC values can also be due to hemorrhages that occur after biopsy. ADC values can vary depending upon the stage of hemorrhage or the width of the cystic/necrosis region. Another limitation of our study was that there were relatively few patients who had undergone adjuvant chemotherapy, and cases of ductal carcinoma in situ were excluded. This could explain why we detected no significant correlation between ORs and ADC values in our study, in general contrast to the results of previous studies.

In conclusion, we found that ADC values obtained on breast DWI were highly correlated with breast cancer NG; therefore, obtaining ADC values represents an important component of treatment. Predictions can be made regarding NG by analyzing ADC values, although additional studies are needed to validate this. The ADC of a lesion can also be used as a prognostic factor to assess its aggressiveness.

Acknowledgments

Authors would like to thank to Department of Radiology, Bakırköy Dr Sadi Konuk Training and Research Hospital.

Footnotes

Ethics Committee Approval: Ethics Committee approval was obtained from Bakırköy Dr. Sadi Konuk Training and Research Hospital (Date: 04.11.2013, Number: 2013/09/05).

Informed Consent: Patients were informed of the study procedures and consent was taken before breast MRI.

Peer-review: Externally peer-reviewed.

Author contributions: Concept - İ.K.Y.; Design - G.A.; Materials - İ.K.Y.; Data Collection and/or Processing - İ.K.Y., G.A., E.K., F.Ç.Y., N.T.; Analysis and/or Interpretation - A.A.G., H.Y.; Literature Search - İ.K.Y., H.Y., N.T.; Writing - İ.K.Y., E.Ö.; Critical Reviews - İ.K.Y., E.Ö.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study has received no financial support.

REFERENCES


Articles from Balkan Medical Journal are provided here courtesy of Trakya University Faculty of Medicine

RESOURCES